<unk> , sold under the brand name Sogroya, is a growth hormone medication.<unk>  is a human growth hormone analog.<unk> -beco is produced in Escherichia coli by recombinant DNA technology. The most common side effects include: back pain, joint paint, indigestion, a sleep disorder, dizziness, tonsillitis, swelling in the arms or lower legs, vomiting, adrenal insufficiency, hypertension, increase in blood creatine phosphokinase (a type of enzyme), weight increase, and anemia. It was approved for medical use in the United States in August 2020.<unk>  is the first human growth hormone (hGH) therapy that adults only take once a week by injection under the skin; other FDA-approved hGH formulations for adults with growth hormone deficiency must be administered daily.
Somapacitan
Meptazinol
Truenat
Sesquimustard
Propylpyrazoletriol
Lesinurad
Lazaretto
Ladostigil